Lonza Walkersville, Inc.
www.lonza.com
Scientific.Support@lonza.com
Scientific Support: 800-521-0390
Walkersville, MD 21793-0127 USA© 2010 Lonza Walkersville, Inc.

Product References®

Poietics CD34+ Cells

Cells+

regulate hematopoiesis. Stem Cells. 2006
May;24(5):1315-27.
8. Chute JP, Saini AA, Chute DJ, Wels MR,
Clark WB, Harlan DM, Park J, Stull MK,Civin C, Davis TA. Ex vivo culture withhuman brain endothelial cells increases theSCID-repopulating capacity of adult humanbone marrow. Blood. 2002; 100(13): 4433-9.
9. Detmer K, Garner RE. Cell surface marker
and cell cycle analysis, hedgehog signaling,
and flow cytometry. Methods Mol Biol.
2007;397:79-90.
10. Doepfner KT, Spertini O, Arcaro A.
Autocrine insulin-like growth factor-I
signaling promotes growth and survival ofhuman acute myeloid leukemia cells via thephosphoinositide 3-kinase/Akt pathway.
Leukemia. 2007 Sep;21(9):1921-30.
11. Ebert BL, Galili N, Tamayo P, Bosco J, Mak
R, Pretz J, Tanguturi S, Ladd-Acosta C,Stone R, Golub TR, Raza A. An erythroid
differentiation signature predicts response tolenalidomide in myelodysplastic syndrome.
PLoS Med. 2008 Feb;5(2):e35.
12. Ebert BL, Lee MM, Pratz JL, SubramanianA, Mak R, Golub TR, Sieff CA. An RNA
interference model of RPS19 deficiency indiamond blackfan anemia recapitulates
defective hematopoesis and rescue bydexamethasone: identification ofdexamethasone responsive genes by
microarray. Blood. 2005 Mar 8.
13. Ebert BL, Pretz J, Bosco J, Chang CY,
Tamayo P, Galili N, Raza A, Root DE, Attar
E, Ellis SR, Golub TR. Identification ofRPS14 as a 5q- syndrome gene by RNA
interference screen. Nature. 2008 Jan
17;451(7176):335-9.
14. Gao N, Rahmani M, Shi X, Dent P, Grant S.
Synergistic antileukemic interactions
between 2-medroxyestradiol (2-ME) andhistone deacetylase inhibitors involve Akt
down-regulation and oxidative stress. Blood.
2006 Jan 1;107(1):241-9.

1. Abernathy DJ, Kleymenova EV, Rose J,
Recio L, Faiola B. Human CD34+
hematopoietic progenitor cells are sensitive
targets for toxicity induced by 1,4benzoquinone. Toxicol Sci. 2004; 79: 82-9.
2. Anderson RM, Stevens DL, Sumption ND,Townsend KM, Goodhead DT, Hill MA.
Effect of linear energy transfer (LET) on thecomplexity of alpha-particle-induced
chromosome aberrations in human CD34+cells. Radiat Res. 2007 May;167(5):541-50.
3. Bagley RG, Walter-Yohrling J, Cao X,Weber W, Simons B, Cook BP Chartrand
SD, Wang C, Madden SL, Teicher BA.
Endothelial precursor cells as a model oftumor endothelium: characterization andcomparison with mature endothelial cells.
Canc Res. 2003 Jan; 63: 5866-73.
4. Bharadwaj U, Li M, Zhang R, Chen C, Yao
Q. Elevated interleukin-6 and G-CSF in
human pancreatic cancer cell conditioned
medium suppress dendritic celldifferentiation and activation. Cancer Res.
2007 Jun 1;67(11):5479-88.
5. Caballero S, Sengupta N, Afzal A, Chang
KH, Li Calzi S, Guberski DL, Kern TS, Grant
MB. Ischemic vascular damage can be
repaired by healthy, but not diabetic,endothelial progenitor cells. Diabetes. 2007
Apr;56(4):960-7.
6. Chang KH, Chan-Ling T, McFarland EL,Afzal A, Pan H, Baxter LC, Shaw LC,Caballero S, Sengupta N, Li Calzi S,Sullivan SM, Grant MB. IGF binding protein3 regulates hematopoietic stem cell andendothelial precursor cell function during
vascular development. Proc Natl Acad Sci US A. 2007 Jun 19;104(25):10595-600.
7. Chute JP, Muramoto GG, Dressman HK,
Wolfe G, Chao NJ, Lin S. Molecular profileand partial functional analysis of novel
endothelial cell-derived growth factors that

1 of 4human megakaryocytes in vitro. Biol Pharm
Bull. 2008 Apr;31(4):569-73.
26. Meck MM, Wierdl M, Wagner LM, Burger
RA, Guichard SM, Krull EJ, Harris LC, Potter
PM, Danks MK. A virus-directed enzyme
prodrug therapy approach to purging
neuroblastoma cells from hematopoietic
cells using adenovirus encoding rabbit
carboxylesterase and CPT-11. Cacn Res.
2001; 61: 5083-9.
27. Moneypenny CG, Shao J, Song Y,Gallagher EP. MLL rearrangements areinduced by low doses of etoposide in human
fetal hematopoietic stem cells.
Carcinogenesis. 2006 Apr; 27(4):874-81.
28. Moutouh-de Parseval LA, Verhelle D, Glezer
E, Jensen-Pergakes K, Ferguson GD, CorralLG, Morris CL, Muller G, Brady H, Chan K.
Pomalidomide and lenalidomide regulate
erythropoiesis and fetal hemoglobin
production in human CD34+ cells. J Clin
Invest. 2008 Jan;118(1):248-58.
29. Murakami S, Sakurai F, Kawabata K, Okada
N, Fujita T, Yamamoto A, Hayakawa T,
Mizuguchi H. Interaction of penton base ArgGly-Asp motifs with integrins is crucial foradenovirus serotype 35 vector transduction
in human hematopoietic cells. Gene Ther.
2007 Nov;14(21):1525-33.
30. Nakamura T, Miyakawa Y, Miyamura A,Yamane A, Suzuki H, Ito M, Ohnishi Y,Ishiwata N, Ikeda Y, Tsuruzoe N. A novel
nonpeptidyl human c-Mpl activator
stimulates human megakaryopoiesis andthrombopoiesis. Blood. 2006 Jun
1;107(11):4300-7.
31. Nguyen TK, Rahmani M, Gao N, Kramer L,Corbin AS, Druker BJ, Dent P, Grant S.
Synergistic interactions between DMAG andmitogen-activated protein kinase kinase 1/2
inhibitors in Bcr/abl+ leukemia cells sensitiveand resistant to imatinib mesylate. ClinCancer Res. 2006 Apr 1;12(7 Pt 1):2239-47.
32. Ong CH, He Z, Kriazhev L, Shan X, Palfree
RG, Bateman A. Regulation of progranulin
expression in myeloid cells. Am J Physiol
Regul Integr Comp Physiol. 2006 Dec;
291(6):R1602-12.
33. Ono F, Sharma BK, Smith CC, Burnett JW,
Aurelian L. CD34+ cells in the peripheral
blood transport herpes simplex virus DNA
fragments to the skin of patients witherythema multiforme (HAEM). J Invest
Dermatol. 2005; 124(6): 1215-24.
34. Ozpolat B, Akar U, Steiner M, ZorrillaCalancha I, Tirado-Gomez M, Colburn N,

15. Gao Z, Golob J, Tanavde VM, Civin CI,
Hawley RG, Cheng L. High levels oftransgene expression following transductionof long-term NOD/SCID-repopulating humancells with a modified lentiviral vector. StemCells. 2001; 19: 247-59.
16. Goodrum F, Reeves M, Sinclair J, High K,
Shenk T. Human cytomegalovirus
sequences expressed in latently infectedindividuals promote a latent infection in vitro.
Blood. 2007 Aug 1;110(3):937-45.
17. Helske S, Syväranta S, Kupari M,
Lappalainen J, Laine M, Lommi J, Turto H,Mäyränpää M, Werkkala K, Kovanen PT,Lindstedt KA. Possible role for mast cellderived cathepsin G in the adverse
remodelling of stenotic aortic valves. EurHeart J. 2006 Jun;27(12):1495-504.
18. Hirohata S, Miura Y, Tomita T, Yoshikawa
H, Ochi T, Chiorazzi N. Enhanced
expression of mRNA for nuclear factor
kappaB1 (p50) in CD34+ cells of the bonemarrow in rheumatoid arthritis. Arthritis Res
Ther. 2006;8(2): R54.
19. Hong Y, Lee K, Yu SS, Kim S, Kim J-G,Shin HY, Kim S. Factors affecting retrovirusmediated gene transfer to human CD34+cells. J of Gene Med. 2004; 6: 724-33.
20. Jordanides NE, Jorgensen HG, Holyoake
TL, Mountford JC. Functional ABCG2 isoverexpressed on primary CML CD34+ cells
and is inhibited by imatinib mesylate. Blood.
2006 Aug 15;108(4):1370-3.
21. Kootstra NA, Munk C, Tonnu N, Landau NR,Verma IM. Abrogation of postentry
restriction of HIV-1-based lentiviral vectortransduction in simian cells. PNAS. 2003;
100(3): 1298-303.
22. Laitala-Leinonen T. Unsatisfactory genetransfer into bone-resorbing osteoclasts withliposomal transfection systems. J Neg
Results in BioMed. 2005; 4(5).
23. Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM,Lai R, Ritz J, Krause DS, Chai L. SALL4, anovel oncogene, is constitutively expressedin human acute myeloid leukemia (AML) andinduces AML in transgenic mice. Blood.
2006 Oct 15;108(8):2726-35.
24. Matsuda A, Okayama Y, Ebihara N, Yokoi
N, Gao P, Hamuro J, Hopkin JM, Kinoshita
S. High-affinity IgE receptor-beta chain
expression in human mast cells. J ImmunolMethods. 2008 Jul 31;336(2):229-34.
25. Matsumura-Takeda K, Ishida T, Sogo S,Isakari Y, Taki T, Sudo T, Kiwada H.
Lactoferrin inhibits platelet production from2 of 4

43. Suzuki K, Kiyokawa N, Taguchi T,Takenouchi H, Saito M, Shimizu T, Okita H,Fujimoto J. Characterization of monocytemacrophage-lineage cells induced from
CD34+ bone marrow cells in vitro. Int JHematol. 2007 Jun;85(5):384-9.
44. Taguchi T, Takenouchi H, Shiozawa Y,
Matsui J, Kitamura N, Miyagawa Y, KatagiriYU, Takahashi T, Okita H, Fujimoto J,Kiyokawa N. Interleukin-7 contributes tohuman pro-B-cell development in a mousestromal cell-dependent culture system. ExpHematol. 2007 Sep;35(9):1398-407.
45. Tei K, Matsumoto T, Mifune Y, Ishida K,
Sasaki K, Shoji T, Kubo S, Kawamoto A,
Asahara T, Kurosaka M, Kuroda R.
Administrations of peripheral blood CD34positive cells contribute to medial collateral
ligament healing via vasculogenesis. StemCells. 2008 Mar;26(3):819-30.
46. Wagner LM, Burger RA, Guichard SM,Raimondi SC, Santana VM, Furman WL,Barnette P, Danks MK. Pilot study toevaluate MYCN expression as aneuroblastoma cell marker to detect minimal
residual disease by RT-PCR. J Pediatr
Hematol Oncol. 2006 Oct;28(10):635-41.
47. Wagner LM, Guichard SM, Burger RA,Morton CL, Straign CM, Ashmun RA, Harris
LC, Houghton PJ, Potter PM, Danks MK.
Efficacy and toxicity of a virus-directed
enzyme prodrug therapy purging method:
preclinical assessment and application tobone marrow samples from neuroblastoma
patients. Canc Res. 2002; 62: 2001-7.
48. Yamane N, Tanaka Y, Ohyabu N, Yamane
S, Maekawa K, Ishizaki J, Suzuki R, Itoh T,Takemoto H. Characterization of novel nonpeptide thrombopoietin mimetics, theirspecies specificity and the activation
mechanism of the thrombopoietin receptor.
Eur J Pharmacol. 2008 May 31;586(1-3):4451.
49. Yang D, Chen Q, Stoll S, Chen X, ZackHoward OM, Oppenheim JJ. Differential
regulation of responsiveness to fMLP andC5a upon dendritic cell maturation:correlation with receptor expression. JImmunol. 2000; 165: 2694-702.
50. Yang S, Rosenberg HF, Chen Q, Dyer KD,Kurosaka K, Oppenheim JJ. Eosinophilderived neurotoxin (EDN), an antimicrobial
protein with chemotactic activities for
dendritic cells. Blood. 2003; 102(9): 3396403.

Danilenko M, Kornblau S, Berestein GL.
Programmed cell death-4 tumor suppressor
protein contributes to retinoic acid-induced
terminal granulocytic differentiation ofhuman myeloid leukemia cells. Mol Cancer
Res. 2007 Jan;5(1):95-108.
35. Rink L, Slupianek A, Stoklosa T,
Nieborowska-Skorska M, Urbanska K,
Seferynska I, Reiss K, Skorski T. Enhanced
phosphorylation of Nbs1, a member of DNA
repair/checkpoint complex Mre11-RAD50Nbs1, can be targeted to increase theefficacy of imatinib mesylate against
BCR/ABL-positive leukemia cells. Blood.
2007 Jul 15;110(2):651-60.
36. Rissanen JP, Suominen MI, Peng Z, Halleen
JM. Secreted tartrate-resistant acidphosphatase 5b is a Marker of osteoclast
number in human osteoclast cultures andthe rat ovariectomy model. Calcif Tissue Int.
2008 Feb;82(2):108-15.
37. Rosato RR, Almenara JA, Coe S, Grant S.
The multikinase inhibitor sorafenib
potentiates TRAIL lethality in humanleukemia cells in association with Mcl-1 andcFLIPL down-regulation. Cancer Res. 2007
Oct 1;67(19):9490-500.
38. Sakurai F, Akitomo K, Kawabata K,Hayakawa T, Mizuguchi H. Downregulationof human CD46 by adenovirus serotype 35vectors. Gene Ther. 2007 Jun;14(11):912-9.
39. Sassetti C, Van Zante A, Rosen SD.
Identification of endoglycan, member of theCD34/podocalyxin family of sialomucins. J
Biol Hcem. 2000; 275(12): 9001-10.
40. Saxonhouse MA, Rimsza LM, Stevens G,Jouei N, Christensen RD, Sola MC. Effectsof hypoxia on megakaryocyte progenitors
obtained from the umbilical cord blood ofterm and preterm neonates. Biol Neonate.
2006; 89(2):104-8.
41. Stoklosa T, Poplawski T, Koptyra M,
Nieborowska-Skorska M, Basak G,
Slupianek A, Rayevskaya M, Seferynska I,
Herrera L, Blasiak J, Skorski T. BCR/ABL
inhibits mismatch repair to protect fromapoptosis and induce point mutations.
Cancer Res. 2008 Apr 15;68(8):2576-80.
42. Sun Y, Stevanovic S, Song M, Schwantes A,
Kirkpatrick CJ, Schadendorf D, Cichutek K.
The kinase insert domain-containing
receptor is an angiogenesis-associatedantigen recognized by human cytotoxic T
lymphocytes. Blood. 2006 Feb 15;
107(4):1476-83.

3 of 4

51. Yoshida A, Takemura H, Inoue H, Miyashita
T, Ueda T. Inhibition of glutathione synthesis
overcomes Bcl-2-mediated topoisomerase
inhibitor resistance and induces
nonapoptotic cell death via mitochondrialindependent pathway. Cancer Res. 2006
Jun 1; 66(11):5772-80.
52. Yu SS, Dan K, Chono H, Chatani E, Mineno
J, Kato I. Transient gene expression
mediated by integrase-defective retroviralvectors. Biochem Biophys Res Commun.
2008 Apr 18;368(4):942-7.
53. Zhou G, Chen J, Lee S, Clark T, Rowley JD,Wang SM. The pattern of gene expression
in human CD34+ stem-progenitor cells.
PNAS. 2001; 98(24): 1396-7.

HPGM Media
1. Drayer AL, Olthof SG, Vellenga E.
Mammalian target of rapamycin is required
for thrombopoietin-induced proliferation ofmegakaryocyte progenitors. Stem Cells.
2006 Jan;24(1):105-14.
2. Massa M, Rosti V, Ramajoli I, Campanelli R,Pecci A, Viarengo G, Meli V, Marchetti M,Hoffman R, Barosi G. Circulating CD34+,
CD 133+, and vascular endothelial growth
factor receptor-2 positive endothelial
progenitor cells in myelofibrosis with myeloid
metaplasia. J Clin Onco. 2005; 23(24):5688-95.
* References not specifically citing the use of Lonza cells, media,
or reagents in their research.
+ Denotes sections containing only the articles published within
the last ten years.

4 of 4